Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine
- 1 November 1975
- Vol. 36 (5) , 1547-1551
- https://doi.org/10.1002/1097-0142(197511)36:5<1547::aid-cncr2820360502>3.0.co;2-t
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Treatment of Acute Myeloid Leukaemia with Daunorubicin, Cytosine Arabinoside, Mercaptopurine, L‐Asparaginase, Prednisone and Thioguanine: Results of Treatment with Five Multiple‐Drug SchedulesBritish Journal of Haematology, 1974
- Treatment of Acute Myeloid Leukaemia according to the Hammersmith Protocol: Preliminary ReportBMJ, 1973
- Management of Adult Acute Myelogenous LeukaemiaBMJ, 1973
- The Treatment of Acute Granulocytic Leukemia in AdultsNew England Journal of Medicine, 1972
- Chemotherapy of acute leukaemiaClinics in Haematology, 1972
- RUBIDOMYCIN IN BLASTIC PHASES OF ACUTE PROMYELOCYTIC AND MYELOBLASTIC LEUKEMIA IN CHILDRENActa Paediatrica, 1971
- The effect of chemotherapy on acute myelogenous leukemia in childrenThe Journal of Pediatrics, 1971
- Epidemiological factors and survival experience in 1770 children with acute leukemia treated by members of children's study group a between 1957 and 1964Cancer, 1969
- DAUNORUBICIN IN THE TREATMENT OF ACUTE MYELOCYTIC LEUKÆMIAThe Lancet, 1969
- Treatment of Acute LeukemiaAnnals of Internal Medicine, 1968